GlaxoSmithKline LLC, Zebulon, NC – FDA Inspections

Inspection records and compliance data for GlaxoSmithKline LLC in Zebulon, North Carolina. 9 FDA inspections on record, last inspected February 20, 2026.

Company Profile

This profile covers GlaxoSmithKline LLC based in Zebulon, North Carolina, United States.

FDA Inspection History

FDA inspections: 9
OAI: 0
VAI: 2
NAI: 6
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected August 24, 2009. Last inspected February 20, 2026.

Most cited issue areas

Complaint Handling Procedure2 inspections
Investigations of discrepancies, failures1 inspection

FDA inspections (9)

Date	Result	FDA center(s)	Insp. #
February 20, 2026	Not classified	Human Drugs	1298596
April 19, 2024	VAI	Human Drugs · Drug Quality Assurance	1229588
January 26, 2018	NAI	Human Drugs · Drug Quality Assurance	1043270
April 21, 2016	VAI	Human Drugs · Drug Quality Assurance	987392
August 21, 2015	NAI	Human Drugs · Drug Quality Assurance	940149
May 3, 2013	NAI	Human Drugs · Drug Quality Assurance	841675
November 20, 2009	NAI	Human Drugs · Drug Quality Assurance	634702
August 24, 2009	NAI	Human Drugs · Drug Quality Assurance	609802
August 24, 2009	NAI	Human Drugs · Drug Quality Assurance	606898

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

PharmaMax Pharmaceuticals, Ltd.

Avara Pharmaceutical Technologies, Inc.

P & L Development LLC

InvaGen Pharmaceuticals, Inc.

Mylan Technologies, Inc.

Braintree, A part of SEBELA Pharmaceuticals

DPT Laboratories Ltd.

HIBROW HEALTHCARE PRIVATE LIMITED

Ferring International Center S.A.

A. R. LIFE SCIENCES PRIVATE LIMITED